310947160	310947160	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
61430183	61430183	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4378651	4378651	CD	B-NP	O
|	|	CC	I-NP	O
3/19/2003	3/19/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/19/2003	3/19/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/25/2003	1/25/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DORIAN	DORIAN	NNP	B-NP	O
GENEREUX	GENEREUX	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Muschaweck	Muschaweck	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
gradually	gradually	RB	B-ADVP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
syncope	syncope	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
acknowledge	acknowledge	VB	I-VP	O
sitting	sit	VBG	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
diet	diet	NN	B-NP	O
or	or	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
medical	medical	JJ	B-NP	O
adherence	adherence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
about	about	IN	B-PP	O
constant	constant	NN	B-NP	O
at	at	IN	B-PP	O
180	180	CD	B-NP	O
pounds	pound	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
note	note	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
but	but	CC	O	O
even	even	RB	B-ADJP	O
now	now	RB	I-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
activities	activity	NNS	B-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
living	living	NN	I-NP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
so	so	IN	O	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Istbern	Istbern	NNP	I-NP	O
Sentne	Sentne	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
,	,	,	O	O
hypoxic	hypoxic	JJ	B-ADJP	O
with	with	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
radiographic	radiographic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	I-NP	O
nitro-paced	nitro-paced	JJ	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
176/74	176/74	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
pleasant	pleasant	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
overweight	overweight	NN	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
times	time	NNS	I-NP	O
person	person	NN	I-NP	O
,	,	,	I-NP	O
place	place	NN	I-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
12	12	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
pulses	pulse	NNS	B-NP	O
parvus	parvus	NN	I-NP	O
et	et	NN	I-NP	O
tardus	tardus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
Kussmaul	Kussmaul	NNP	I-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
rales	rale	NNS	B-NP	O
one-half	one-half	JJ	I-NP	O
way	way	NN	I-NP	O
up	up	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fields	field	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
bradycardic	bradycardic	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slurred	slurred	JJ	I-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
cool	cool	JJ	B-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
neurologic	neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
patient	patient	NN	B-NP	O
being	be	VBG	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
motor	motor	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Revealed	Reveal	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
142	142	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
105	105	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
31	31	CD	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
152	152	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
41.8	41.8	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
289	289	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.8	8.8	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
coags	coag	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
32.7	32.7	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatine	creatine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
41	41	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
MB	MB	NN	I-NP	B-protein
fraction	fraction	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
1.9	1.9	CD	B-ADVP	I-protein
,	,	,	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
,	,	,	O	O
brain	brain	NN	B-NP	O
natriuretic	natriuretic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
885	885	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
at	at	IN	B-PP	O
48	48	CD	B-NP	O
beats/minute	beats/minute	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
from	from	IN	B-PP	O
change	change	NN	B-NP	O
from	from	IN	B-PP	O
1/8	1/8	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NNP	B-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
AVA	AVA	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
acute	acute	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
two-vessel	two-vessel	JJ	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OM-2	OM-2	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
bladder	bladder	NN	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
before	before	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
48	48	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Levoxyl	Levoxyl	NN	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Sunday	Sunday	NNP	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
all	all	DT	B-NP	O
vises	vise	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	I-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
Severi	Severi	NNP	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
in	in	IN	B-PP	O
HPI	HPI	NN	B-NP	B-cell_line
,	,	,	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
medications	medication	NNS	B-NP	O
changes	change	NNS	I-NP	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chief	chief	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
dietary	dietary	JJ	B-NP	O
or	or	CC	I-NP	O
medication	medication	NN	I-NP	O
issues	issue	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
likely	likely	RB	I-VP	O
given	give	VBN	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
excellent	excellent	JJ	I-NP	O
awareness	awareness	NN	I-NP	O
and	and	CC	I-NP	O
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
suspicion	suspicion	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
blood	blood	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
oxygen	oxygen	NN	B-NP	O
demand	demand	NN	I-NP	O
and	and	CC	O	O
creating	create	VBG	B-VP	O
diastolic	diastolic	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
gradual	gradual	JJ	B-NP	O
progression	progression	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
rule	rule	NN	B-NP	O
out	out	IN	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
84.7	84.7	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
83.7	83.7	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
actually	actually	RB	B-VP	O
continued	continue	VBD	I-VP	O
her	her	PRP	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
after	after	IN	B-PP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
noted	note	VBN	I-VP	O
below	below	IN	B-PP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
actually	actually	RB	I-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
urinate	urinate	VB	I-VP	O
even	even	RB	B-ADVP	O
more	more	RBR	I-ADVP	O
so	so	RB	I-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
100s	100	NNS	I-NP	O
,	,	,	O	O
consistently	consistently	RB	B-ADVP	O
below	below	IN	B-PP	O
150	150	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
above	above	IN	B-PP	O
100	100	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
several	several	JJ	B-NP	O
points	point	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
bradycardia	bradycardia	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
junctional	junctional	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
also	also	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
6/21/2003	6/21/2003	CD	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
dual-chamber	dual-chamber	JJ	I-NP	O
PPM	PPM	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
before	before	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
oozing	oozing	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Electrophysiologists	Electrophysiologist	NNS	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
device	device	NN	I-NP	O
and	and	CC	O	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
working	work	VBG	I-VP	O
properly	properly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gutirrez	Gutirrez	NNP	I-NP	O
on	on	IN	B-PP	O
4/13/2003	4/13/2003	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
limit	limit	VB	I-VP	O
her	her	PRP$	B-NP	O
driving	driving	NN	I-NP	O
until	until	IN	B-PP	O
that	that	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
advised	advise	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cephalexin	cephalexin	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
any	any	DT	B-NP	O
problems	problem	NNS	I-NP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Richel	Richel	NNP	I-NP	O
at	at	IN	B-PP	O
telephone	telephone	NN	B-NP	O
#	#	#	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
851	851	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
491-7503	491-7503	CD	I-NP	O
,	,	,	O	O
adetc	adetc	NN	B-NP	O
#	#	#	B-NP	O
33243	33243	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
PFTs	PFT	NNS	B-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
9/18	9/18	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	O	O
,	,	,	O	O
FEV1	FEV1	NN	B-NP	O
of	of	IN	B-PP	O
77	77	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	O	O
,	,	,	O	O
and	and	CC	O	O
FEV1	FEV1	NN	B-NP	B-protein
to	to	TO	B-PP	O
FVC	FVC	NN	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
108	108	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
FEF	FEF	NN	B-NP	O
25/75	25/75	CD	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TLC	TLC	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
SVC	SVC	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
residual	residual	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	O	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
RV/TLC	RV/TLC	NN	I-NP	B-protein
of	of	IN	B-PP	O
72	72	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
DLCO	DLCO	NN	I-NP	O
uncorrected	uncorrected	JJ	I-NP	O
was	be	VBD	B-VP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
her	her	PRP$	B-NP	O
DLCO	DLCO	NN	I-NP	O
corrected	correct	VBN	B-VP	O
was	be	VBD	B-VP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
had	have	VBD	B-VP	O
low	low	JJ	B-NP	O
O2	O2	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
80s	80	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
often	often	RB	B-ADVP	O
below	below	IN	B-PP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
consistently	consistently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid-80	mid-80	CD	I-NP	O
%	%	NN	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
not	not	RB	B-VP	O
depending	depend	VBG	I-VP	O
on	on	IN	B-PP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
probe	probe	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
weaned	wean	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
things	thing	NNS	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	B-protein
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
liver	liver	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
commented	comment	VBN	I-VP	O
on	on	IN	B-PP	O
below	below	IN	B-PP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Radiology	Radiology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
this	this	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
multifocal	multifocal	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
ground-glass	ground-glass	JJ	I-NP	O
opacities	opacity	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
haziness	haziness	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
septal	septal	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
basil	basil	NN	I-NP	O
predominance	predominance	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
borderline	borderline	JJ	I-NP	O
mediastinal	mediastinal	JJ	I-NP	O
nodes	node	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
mediastinum	mediastinum	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
AP	AP	NN	I-NP	B-DNA
window	window	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
with	with	IN	B-PP	O
the	the	DT	B-NP	O
largest	large	JJS	I-NP	O
node	node	NN	I-NP	O
on	on	IN	B-PP	O
image	image	NN	B-NP	O
21	21	CD	I-NP	O
measuring	measure	VBG	B-VP	O
1.3	1.3	CD	B-NP	O
x	x	SYM	I-NP	O
2	2	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
calcifications	calcification	NNS	I-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
with	with	IN	B-PP	O
multi-chamber	multi-chamber	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
particularly	particularly	RB	B-NP	O
dense	dense	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
calcifications	calcification	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
right	right	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
pleural	pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

Visualized	Visualize	VBN	B-NP	O
organs	organ	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
abdomen	abdoman	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
ill-defined	ill-defined	JJ	I-NP	O
low	low	JJ	I-NP	O
attenuation	attenuation	NN	I-NP	O
foci	focus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
window	window	NN	I-NP	O
shows	show	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
thoracic	thoracic	JJ	I-NP	O
degenerative	degenerative	JJ	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
sternal	sternal	JJ	B-NP	O
wires	wire	NNS	I-NP	O
and	and	CC	O	O
epicardial	epicardial	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
leads	lead	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
lung	lung	NN	I-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
other	other	JJ	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
possibilities	possibility	NNS	I-NP	O
including	include	VBG	B-PP	O
atypical	atypical	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
hypersensitivity	hypersensitivity	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
or	or	CC	O	O
less	less	RBR	B-NP	O
likely	likely	JJ	I-NP	O
lymphangitic	lymphangitic	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
workup	workup	VB	I-VP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
attained	attain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
liver	liver	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mass	mass	NN	I-NP	O
2.9	2.9	CD	I-NP	O
x	x	SYM	I-NP	O
2.8	2.8	CD	I-NP	O
x	x	SYM	I-NP	O
2.2	2.2	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
hyperechoic	hyperechoic	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
segment	segment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
mass	mass	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
7/21/203	7/21/203	CD	B-NP	O
and	and	CC	I-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
gallbladder	gallbladder	NN	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
stones	stone	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
tree	tree	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
and	and	CC	O	O
left	left	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
,	,	,	O	O
pancreas	pancreas	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
poorly	poorly	RB	I-VP	O
visualized	visualize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
spleen	spleen	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
,	,	,	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
small	small	JJ	B-NP	O
and	and	CC	I-NP	O
prominent	prominent	JJ	I-NP	O
hepatic	hepatic	JJ	I-NP	O
veins	vein	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
radiologist	radiologist	NN	I-NP	O
's	's	POS	B-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ectogenic	ectogenic	JJ	I-NP	O
mass	mass	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
corresponded	correspond	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
reported	report	VBN	B-VP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
CTs	CT	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
hemangioma	hemangioma	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
ectogenic	ectogenic	JJ	I-NP	O
masses	mass	NNS	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
hold	hold	VB	I-VP	O
her	her	PRP$	B-NP	O
breath	breath	NN	I-NP	O
sufficiently	sufficiently	RB	B-ADVP	O
well	well	RB	I-ADVP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
mass	mass	NN	I-NP	O
with	with	IN	B-PP	O
Doppler	Doppler	NNP	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
PMD	PMD	NN	I-NP	O
should	should	MD	B-VP	O
either	either	RB	I-VP	O
get	get	VB	I-VP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
CT	CT	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
radiologist	radiologist	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
MRI	MRI	NN	B-NP	B-protein
but	but	CC	O	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
impossible	impossible	JJ	B-ADJP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
confirmation	confirmation	NN	B-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
prominent	prominent	JJ	B-NP	O
hepatic	hepatic	JJ	I-NP	O
veins	vein	NNS	I-NP	O
possibly	possibly	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
ISSUES	ISSUES	NNS	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
25	25	CD	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
controls	control	VBZ	B-VP	O
generally	generally	RB	B-ADVP	O
below	below	IN	B-PP	O
fingerstick	fingerstick	NN	B-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Niferex	Niferex	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
being	be	VBG	B-VP	O
41.8	41.8	CD	B-NP	O
and	and	CC	O	O
discharge	discharge	NN	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
being	be	VBG	B-VP	O
38.8	38.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
6.8	6.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
3.2	3.2	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
before	before	IN	B-PP	O
her	her	PRP$	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
6/21/2003	6/21/2003	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
reinstituted	reinstitute	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
same	same	JJ	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Garder	Garder	NNP	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
5/25/2003	5/25/2003	CD	B-NP	O
and	and	CC	O	O
be	be	VB	B-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
admission	admission	NN	B-NP	O
medicines	medicine	NNS	I-NP	O
except	except	IN	B-PP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
taking	take	VBG	I-VP	O
cephalexin	cephalexin	NN	B-NP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
difference	difference	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
can	can	MD	B-VP	O
consider	consider	VB	I-VP	O
can	can	MD	B-VP	O
titrating	titrate	VBG	I-VP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
medicines	medicine	NNS	I-NP	O
and/or	and/or	CC	O	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-7893755	9-7893755	CD	B-NP	O
LMS	LMS	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Stanley	Stanley	NNP	B-NP	O
Malek	Malek	NNP	I-NP	O
BH	BH	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MACENTEE	MACENTEE	NNP	B-NP	O
,	,	,	O	O
ERNIE	ERNIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOWN	LOWN	NNP	B-NP	O
,	,	,	O	O
LINDSEY	LINDSEY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6788148	6788148	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/23/03	8/23/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/23/03	8/23/03	CD	B-NP	O

